Skip to Main Content

I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients

Conditions

Women's Health | COVID-19 Inpatient | COVID-19 Outpatient

Phase COVID-II

What is the purpose of this trial?

Identify agents that will result in substantial improvements to the clinical condition of participants with COVID-19.

  • Trial with
    QuantumLeap Healthcare Collaborative
  • Start Date
    10/07/2020
  • End Date
    07/23/2022
Trial Image

For more information about this study, contact:

Jackie Prinz

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/26/2020
  • Study HIC
    #2000028816